Press release
Cancer Tissue Diagnostics Market will Expand at a CAGR of 8.3% During 2016-2026
The National Cancer Institute (NCI), which is a part of National Institutes of Health (NIH) in the US estimated 1,685,210 new cases of cancer in the country in 2016. In the same year, NCI also projected 595,690 deaths due to carcinogenic ailments. Cancer research activities have surged rapidly over the past few years, which has led to more product approvals for cancer diagnostic and treatment purposes. A recent study conducted by Future Market Insights (FMI) reveals that the global cancer tissue diagnostics market, which is currently valued at over US$ 4345 Mn, will expand at a healthy CAGR of 8.3% during the forecast period (2016-2026). During these ten years of the forecast, the global demand for cancer tissue diagnostics is expected to grow by leaps and bounds as diagnostic technologies will continue to get more efficient and credible.Browse Full Report @ https://www.futuremarketinsights.com/reports/cancer-tissue-diagnostics-market
FMI’s report titled “Cancer Tissue Diagnostics Market: Global Industry Analysis and Opportunity Assessment 2016–2026” also cites that North America represents the most lucrative market for cancer tissue diagnostics, followed by Europe and APAC. In 2016, North America accounted for more than 36% share of the global market. The cancer tissue diagnostics market in this region is expected to reach a valuation of US$ 4,017.7 Mn towards the end of 2026. This growth is primarily attributed to factors such as the constantly extending list of cancer biomarkers and the presence of advance healthcare infrastructures in the region. Meanwhile, Asia Pacific excluding Japan (APEJ) is also anticipated to witness a strong growth of its market over the next couple of years. By 2026-end, the region’s market is expected to reach US$ 1,107.7 Mn in terms of revenue.
Report Overview With TOC@ https://www.futuremarketinsights.com/reports/cancer-tissue-diagnostics-market/toc
The National Cancer Institute (NCI), which is a part of National Institutes of Health (NIH) in the US estimated 1,685,210 new cases of cancer in the country in 2016. In the same year, NCI also projected 595,690 deaths due to carcinogenic ailments. Cancer research activities have surged rapidly over the past few years, which has led to more product approvals for cancer diagnostic and treatment purposes. A recent study conducted by Future Market Insights (FMI) reveals that the global cancer tissue diagnostics market, which is currently valued at over US$ 4345 Mn, will expand at a healthy CAGR of 8.3% during the forecast period (2016-2026). During these ten years of the forecast, the global demand for cancer tissue diagnostics is expected to grow by leaps and bounds as diagnostic technologies will continue to get more efficient and credible.
FMI’s report titled “Cancer Tissue Diagnostics Market: Global Industry Analysis and Opportunity Assessment 2016–2026” also cites that North America represents the most lucrative market for cancer tissue diagnostics, followed by Europe and APAC. In 2016, North America accounted for more than 36% share of the global market. The cancer tissue diagnostics market in this region is expected to reach a valuation of US$ 4,017.7 Mn towards the end of 2026. This growth is primarily attributed to factors such as the constantly extending list of cancer biomarkers and the presence of advance healthcare infrastructures in the region. Meanwhile, Asia Pacific excluding Japan (APEJ) is also anticipated to witness a strong growth of its market over the next couple of years. By 2026-end, the region’s market is expected to reach US$ 1,107.7 Mn in terms of revenue.
Buy Full Cancer Tissue Diagnostics Market Report @ https://www.futuremarketinsights.com/checkout/4191
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Tissue Diagnostics Market will Expand at a CAGR of 8.3% During 2016-2026 here
News-ID: 797817 • Views: …
More Releases from Future Market Insights
Marine Protein Hydrolysate Market Set to Reach USD 454.6 Million by 2035, Driven …
The global marine protein hydrolysate market is expected to grow from USD 298.4 million in 2025 to USD 454.6 million by 2035, at a CAGR of 4.3%, creating an absolute dollar opportunity of USD 156.2 million. Market expansion is propelled by growing applications in dietary supplements, functional foods, animal feed, aquaculture, and cosmetics, where marine proteins provide bioactive peptides with high digestibility and nutritional benefits.
The market is witnessing a two-phase…
Antimicrobial Feed Additives Market Reaching USD 6.5 Billion by 2035 Amid Antibi …
The Antimicrobial Feed Additives Market is projected to expand from USD 3,640.0 million in 2025 to USD 6,515.9 million by 2035, marking an impressive 79% growth. The market is expected to nearly double over the decade with a 6.0% CAGR, fueled by rising consumer demand for antibiotic-free animal products, regulatory pressures, and innovations in acidifiers, probiotics, and phytogenic solutions.
Explore trends before investing - request a sample report today! https://www.futuremarketinsights.com/reports/sample/rep-gb-26556
Market Growth…
Global Enzymes Market Projected to Grow Steadily at 6.8% CAGR, Hitting USD 29.7 …
The global enzymes market is estimated at USD 15.4 billion in 2025 and is projected to reach USD 29.7 billion by 2035, expanding at a CAGR of 6.8%. Demand continues to accelerate as manufacturers adopt enzymes to enhance productivity under mild conditions while reducing energy usage and chemical dependency. Food and beverage producers remain the largest buyers, especially in bakery, dairy, and brewing operations.
In healthcare applications, diagnostic tools and therapeutic…
Carbon Labeled Packaged Meal Market Growth Set at 6.3% CAGR Through 2035, Driven …
The worldwide carbon-labeled packaged meal market is entering a transformative growth phase, with transparency-driven food choices quickly shifting from niche demand to mainstream consumption. A valuation of USD 678.2 Million is projected by 2025, and the market is expected to reach USD 1,251.9 Million by 2035, expanding at a 6.3% CAGR as consumers prioritize verifiable, climate-conscious nutrition.
Explore trends before investing - request a sample report today! https://www.futuremarketinsights.com/reports/sample/rep-gb-26678
Climate Transparency Becomes a…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
